Context Partners Fund »

PDL BioPharma shares owned by Context Partners Fund

Quarter-by-quarter ownership of PDL BioPharma shares owned by Context Partners Fund from 13F filings

Historical chart of Context Partners Fund investment in PDL BioPharma

Tip: Access up to 7 years of quarterly data

All positions including PDL BioPharma held by Context Partners Fund consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in PDL BioPharma by Context Partners Fund

Quarter filed Position value Share count Share price at filing
2020-09-30 $1.5M 465k 3.15

More positions owned by Context Partners Fund

8X8 Note 0.500% 2/0 (Principal)
Sea Debt 2.375%12/0 (Principal)
Veoneer Incorporated Note 4.000% 6/0 (Principal)
Intercept Pharmaceuticals In Note 3.250% 7/0 (Principal)
Amag Pharmaceuticals Note 3.250% 6/0 (Principal)
Cf Finance Acquisition Corp Unit 08/01/2027
Churchill Capital Corp Iv Unit 99/99/9999
Nanthealth Note 5.500%12/1 (Principal)
Infinera Corporation Note 2.125% 9/0 (Principal)
Pra Group Note 3.500% 6/0 (Principal)
Flexion Therapeutics Note 3.375% 5/0 (Principal)
Navsight Hldgs Unit 99/99/9999
Retrophin Note 2.500% 9/1 (Principal)
Seacor Holdings Note 2.500%12/1 (Principal)
Iqiyi Debt 3.750%12/0 (Principal)

View all positions for Context Partners Fund

Top funds holding PDL BioPharma

Hancock Bank Trust Department
Argent Trust
Diversified Trust Company
Ancora Advisors
Rhumbline Advisers
Westside Investment Management

View all funds holding PDL BioPharma